These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26470437)

  • 1. [THE SERUM LEVEL OF TOTAL AND OLIGOMERIC FRACTIONS OF SOLUBLE MOLECULES CD38 UNDER MALIGNANT TUMORS OF CERVIX AND UTERINE BODY].
    Novikov VV; Mamaeva ME; Aliasova AV; Hazov MV; Kasatova ES; Shumilova SV; Karaulov AV
    Klin Lab Diagn; 2015 May; 60(5):32-6. PubMed ID: 26470437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
    Ferdeghini M; Gadducci A; Prontera C; Marrai R; Malagnino G; Annicchiarico C; Fioretti P; Bianchi R
    Anticancer Res; 1993; 13(3):709-13. PubMed ID: 8317901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobody-based dual epitopes protein identification (DepID) assay for measuring soluble CD38 in plasma of multiple myeloma patients.
    Li T; Li SL; Fang C; Hou YN; Zhang Q; Du X; Lee HC; Zhao YJ
    Anal Chim Acta; 2018 Oct; 1029():65-71. PubMed ID: 29907292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of different forms of soluble CD38 antigen in burned patients.
    Lebedev MJ; Egorova NI; Sholkina MN; Vilkov SA; Baryshnikov AJ; Novikov VV
    Burns; 2004 Sep; 30(6):552-6. PubMed ID: 15302420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cytosolic chaperone complex controls folding and degradation of type III CD38.
    Wu Y; Zhang J; Fang L; Lee HC; Zhao YJ
    J Biol Chem; 2019 Mar; 294(11):4247-4258. PubMed ID: 30670591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of RCAS1 as a biomarker of uterine cancer.
    Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
    Gynecol Oncol; 2006 Dec; 103(3):924-31. PubMed ID: 16842844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daratumumab (anti-CD38) induces loss of CD38 on red blood cells.
    Sullivan HC; Gerner-Smidt C; Nooka AK; Arthur CM; Thompson L; Mener A; Patel SR; Yee M; Fasano RM; Josephson CD; Kaufman RM; Roback JD; Lonial S; Stowell SR
    Blood; 2017 Jun; 129(22):3033-3037. PubMed ID: 28373263
    [No Abstract]   [Full Text] [Related]  

  • 8. CD38-mediated ribosylation of proteins.
    Grimaldi JC; Balasubramanian S; Kabra NH; Shanafelt A; Bazan JF; Zurawski G; Howard MC
    J Immunol; 1995 Jul; 155(2):811-7. PubMed ID: 7608558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of NAD glycohydrolase activity in uterine cervix cancers is caused by infiltration of lymphocytes.
    Han MK; Kwark OS; Jang KY; Lee DG; Oh BC; An NH; Kim UH
    Cancer Lett; 1999 Nov; 146(2):201-5. PubMed ID: 10656627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cells naturally induced during dengue virus infection release soluble CD27, the plasma level of which is associated with severe forms of pediatric dengue.
    Castañeda DM; Salgado DM; Narváez CF
    Virology; 2016 Oct; 497():136-145. PubMed ID: 27467579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
    Gocze PM; Vahrson HW; Freeman DA
    Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Pre-treatment Serum C-Reactive Protein Level in Patients with Adenocarcinoma of the Uterine Cervix.
    Bodner-Adler B; Kimberger O; Schneidinger C; Kölbl H; Bodner K
    Anticancer Res; 2016 Sep; 36(9):4691-6. PubMed ID: 27630314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma.
    Petraglia F; Florio P; Luisi S; Gallo R; Gadducci A; Viganò P; Di Blasio AM; Genazzani AR; Vale W
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1194-200. PubMed ID: 9543140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of abnormal plasma amino acid profile-based indexes in patients with gynecological malignant tumors after curative treatment.
    Suzuki Y; Tokinaga-Uchiyama A; Mizushima T; Maruyama Y; Mogami T; Shikata N; Ikeda A; Yamamoto H; Miyagi E
    BMC Cancer; 2018 Oct; 18(1):973. PubMed ID: 30314462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of the Content of Systemic and Endobronchial Soluble Molecules of CD25, CD38, CD8, and HLA-I-CD8 and Lung Function Parameters in COPD Patients.
    Kubysheva N; Postnikova L; Soodaeva S; Novikov V; Eliseeva T; Batyrshin I; Li T; Klimanov I; Chuchalin A
    Dis Markers; 2017; 2017():8216723. PubMed ID: 28848245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concentration of epidermal growth factor (EGF) in serum of women with endometrial cancer].
    Tomaszewski J; Miturski R; Kotarski J
    Ginekol Pol; 1996 May; 67(5):248-53. PubMed ID: 8925996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD38 enhances the proliferation and inhibits the apoptosis of cervical cancer cells by affecting the mitochondria functions.
    Liao S; Xiao S; Chen H; Zhang M; Chen Z; Long Y; Gao L; Zhu G; He J; Peng S; Xiong W; Zeng Z; Li Z; Zhou M; Li X; Ma J; Wu M; Xiang J; Li G; Zhou Y
    Mol Carcinog; 2017 Oct; 56(10):2245-2257. PubMed ID: 28544069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of uterine malignancies.
    Brown L
    Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):433-47. PubMed ID: 18499412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transient form of serum albumin in gynecologic cancer].
    Rybalka AN; Bagdasar'ian SN; Garina TN; Karpilenko TM; Kasymova GA
    Biull Eksp Biol Med; 1984 Jan; 97(1):76-9. PubMed ID: 6692030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma-associated mucin serum markers CA M26 and CA M29: efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix.
    Yedema KA; Kenemans P; Wobbes T; van Kamp GJ; de Bruijn HW; Thomas CM; Massuger LF; Schijf CP; Bon GG; Vermorken JB
    Int J Cancer; 1991 Jan; 47(2):170-9. PubMed ID: 1988362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.